🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

1 Tablet(s) Serving Size
Other Combinations Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 80.0mg (136 products)
Median 80.0mg This product: 40mg
Proprietary Blend
825 mg

Other Ingredients

Stearic Acid Sorbitol modified Cellulose Gum Silica Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (79% of products) Nutrient (2% of products) No Claim (1% of products)

Target Groups

Adult Female (18 - 50 Years) Menopause

Product Information

📋 Directions for Use

Suggested Use: 1 tablet 3 times daily between meals.

⚠️ Warnings & Precautions

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

Warning: Do not use if you are pregnant, may become pregnant, or breastfeeding. If you are taking Interferon or any other prescription drugs, consult your physician before using this product.

🧪 Formulation Notes

Planetary Herbals Menochange cimicifuga-vitex compound is a comprehensive botanical preparation, used to support a woman's changing cycle through menopause.

It contains a standardized black cohosh extract along with wild yam root extract from Native American herbal traditions, and Europe's premier female regulator, chaste tree berry (Vitex agnus-castus). These are combined with traditional Chinese herbs, including dong quai, renowned for their ability to support a healthy reproductive system.

Additional Information

Formulated by Michael Tierra L.Ac, O.M.D

PF0325 REV C161-D

Product Details

UPC / SKU 0 21078 10325 7
DSLD Entry Date 2017-08-22
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 76869
Data Updated 2026-04-11

Research Evidence

31 Research Sources
49 Avg Quality Score
23 Systematic Review
5 Meta Analysis
1 Rct
1 Openfda Safety
B [Efficacy of black cohosh extracts for improving low estrogen status induced by postoperative GnRHa treatment in patients with endometriosis: a systematic review]
Systematic Review Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2020
B Black cohosh (Cimicifuga spp.) for menopausal symptoms
Meta Analysis The Cochrane database of systematic reviews 2012
B Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
Systematic Review BJOG : an international journal of obstetrics and gynaecology 2017
C Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract
Meta Analysis Menopause (New York, N.Y.) 2011
C Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence
Meta Analysis Climacteric : the journal of the International Menopause Society 2021
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2007
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2011
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2010
C Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis
Meta Analysis Menopause (New York, N.Y.) 2023
C Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis
Meta Analysis Alternative therapies in health and medicine 2010
View all evidence for Black Cohosh →

Compare Similar Products

View all Black Cohosh products →